glp 1 maintenance dose after weight loss discontinuation of GLP-1 therapies Conceptual framework for ongoing care
Description
When a person chooses to stop taking metformin, or any other antidiabetic medication, there is a risk of symptoms becoming worse

Importantly, GLP-1 receptors are found not only in neurons but also in glial cells, which mediate its effects on brain health by regulating energy balance and maintaining neural circuits

The gastrointestinal effects typically emerge during dose escalation and may diminish with continued use as physiologic adaptation occurs
NAION, which stands for nonarteritic anterior ischemic optic neuropathy, is an eye condition that affects the blood vessels in the eye and can lead to long-term vision loss

People who took Zepbound, which is a GLP-1 RA drug, and were diagnosed with NAION can speak to an attorney about whether or not they qualify to join this litigation

FDA Approves Oral Semaglutide as First GLP Pill for Weight Loss The FDA approval of oral semaglutide marks a major breakthrough as the first GLP-1 pill available for weight loss, offering a needle-free treatment option